Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 12 | 2019 | 930 | 2.830 |
Why?
|
Alzheimer Disease | 6 | 2019 | 312 | 2.110 |
Why?
|
Dementia | 5 | 2018 | 234 | 1.610 |
Why?
|
Cognition | 5 | 2018 | 526 | 1.180 |
Why?
|
Blood Pressure | 5 | 2018 | 806 | 1.060 |
Why?
|
Hydroxycholesterols | 2 | 2013 | 2 | 0.880 |
Why?
|
Disease Progression | 2 | 2014 | 572 | 0.850 |
Why?
|
Insulin | 2 | 2015 | 346 | 0.840 |
Why?
|
Magnetic Resonance Imaging | 6 | 2018 | 1219 | 0.810 |
Why?
|
Cerebrovascular Disorders | 2 | 2018 | 48 | 0.560 |
Why?
|
Dementia, Vascular | 1 | 2015 | 13 | 0.550 |
Why?
|
Cholesterol | 2 | 2013 | 229 | 0.520 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2018 | 1379 | 0.510 |
Why?
|
Carotid Artery, Common | 1 | 2014 | 37 | 0.510 |
Why?
|
Brain Ischemia | 1 | 2016 | 136 | 0.510 |
Why?
|
Stroke | 2 | 2018 | 548 | 0.500 |
Why?
|
Humans | 22 | 2019 | 29123 | 0.500 |
Why?
|
African Americans | 2 | 2018 | 1373 | 0.490 |
Why?
|
Cohort Studies | 7 | 2018 | 1688 | 0.480 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 109 | 0.480 |
Why?
|
Biological Transport | 1 | 2013 | 62 | 0.470 |
Why?
|
Frontal Lobe | 1 | 2013 | 45 | 0.460 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 180 | 0.420 |
Why?
|
Hypertension | 2 | 2015 | 910 | 0.410 |
Why?
|
Diabetes Complications | 3 | 2018 | 171 | 0.410 |
Why?
|
Male | 15 | 2018 | 17815 | 0.400 |
Why?
|
Geriatric Assessment | 1 | 2013 | 355 | 0.400 |
Why?
|
Female | 14 | 2018 | 18173 | 0.390 |
Why?
|
Apolipoprotein E4 | 3 | 2018 | 58 | 0.380 |
Why?
|
Aging | 2 | 2013 | 881 | 0.360 |
Why?
|
Weight Loss | 1 | 2012 | 413 | 0.350 |
Why?
|
Risk Factors | 5 | 2018 | 3537 | 0.350 |
Why?
|
Aged | 10 | 2018 | 9492 | 0.340 |
Why?
|
Cognition Disorders | 3 | 2018 | 390 | 0.330 |
Why?
|
Aged, 80 and over | 7 | 2018 | 3719 | 0.330 |
Why?
|
Case-Control Studies | 3 | 2013 | 859 | 0.290 |
Why?
|
Neuropsychological Tests | 3 | 2018 | 379 | 0.290 |
Why?
|
Obesity | 2 | 2014 | 1063 | 0.280 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 1017 | 0.280 |
Why?
|
Ankle Brachial Index | 2 | 2014 | 37 | 0.240 |
Why?
|
Double-Blind Method | 2 | 2014 | 503 | 0.220 |
Why?
|
Middle Aged | 7 | 2018 | 10834 | 0.210 |
Why?
|
Age Factors | 2 | 2015 | 1108 | 0.190 |
Why?
|
Positron-Emission Tomography | 2 | 2018 | 172 | 0.180 |
Why?
|
Organ Size | 2 | 2018 | 196 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 50 | 0.170 |
Why?
|
Hypotension, Orthostatic | 1 | 2018 | 10 | 0.170 |
Why?
|
Animals | 3 | 2015 | 7300 | 0.160 |
Why?
|
Vascular Diseases | 1 | 2019 | 61 | 0.160 |
Why?
|
Time Factors | 2 | 2014 | 2001 | 0.160 |
Why?
|
Amyloid | 1 | 2018 | 17 | 0.160 |
Why?
|
Energy Metabolism | 1 | 2018 | 139 | 0.160 |
Why?
|
Retrospective Studies | 3 | 2018 | 3112 | 0.150 |
Why?
|
Risk | 1 | 2018 | 289 | 0.150 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 1362 | 0.150 |
Why?
|
Mitochondria | 1 | 2018 | 174 | 0.150 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2018 | 109 | 0.140 |
Why?
|
Atrophy | 2 | 2013 | 51 | 0.140 |
Why?
|
Acute Disease | 1 | 2016 | 239 | 0.130 |
Why?
|
Ethnic Groups | 1 | 2018 | 440 | 0.130 |
Why?
|
Prediabetic State | 1 | 2015 | 54 | 0.130 |
Why?
|
Multivariate Analysis | 2 | 2018 | 637 | 0.130 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2015 | 11 | 0.130 |
Why?
|
Glucose | 1 | 2015 | 163 | 0.130 |
Why?
|
Inflammation | 1 | 2018 | 508 | 0.120 |
Why?
|
Receptor, EphA1 | 1 | 2013 | 2 | 0.120 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 23 | 0.120 |
Why?
|
Ginkgo biloba | 1 | 2013 | 19 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2013 | 31 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2013 | 60 | 0.110 |
Why?
|
Plant Extracts | 1 | 2013 | 60 | 0.110 |
Why?
|
Regression Analysis | 1 | 2013 | 274 | 0.110 |
Why?
|
Homeostasis | 1 | 2013 | 127 | 0.110 |
Why?
|
Overweight | 1 | 2014 | 256 | 0.110 |
Why?
|
Follow-Up Studies | 2 | 2018 | 2109 | 0.110 |
Why?
|
Pennsylvania | 1 | 2012 | 77 | 0.110 |
Why?
|
Insulin Resistance | 1 | 2015 | 449 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 342 | 0.110 |
Why?
|
Fasting | 1 | 2012 | 93 | 0.110 |
Why?
|
Adult | 3 | 2014 | 8426 | 0.110 |
Why?
|
Atherosclerosis | 1 | 2018 | 698 | 0.110 |
Why?
|
Down-Regulation | 1 | 2012 | 143 | 0.110 |
Why?
|
Brain Infarction | 1 | 2011 | 10 | 0.100 |
Why?
|
Longitudinal Studies | 1 | 2014 | 721 | 0.100 |
Why?
|
Linear Models | 1 | 2012 | 426 | 0.100 |
Why?
|
Body Mass Index | 1 | 2012 | 865 | 0.090 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 787 | 0.070 |
Why?
|
Young Adult | 1 | 2012 | 2402 | 0.070 |
Why?
|
Treatment Outcome | 1 | 2012 | 3101 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 1119 | 0.060 |
Why?
|
United States | 2 | 2019 | 3632 | 0.050 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 7 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 42 | 0.040 |
Why?
|
Cerebrovascular Circulation | 1 | 2019 | 95 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2018 | 116 | 0.040 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 52 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2018 | 64 | 0.040 |
Why?
|
Sex Distribution | 1 | 2018 | 186 | 0.040 |
Why?
|
Age Distribution | 1 | 2018 | 198 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2018 | 181 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2018 | 232 | 0.040 |
Why?
|
Databases, Factual | 1 | 2018 | 332 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 709 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2018 | 863 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2014 | 454 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 1306 | 0.030 |
Why?
|
Hawaii | 1 | 2011 | 3 | 0.030 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 7 | 0.030 |
Why?
|
Autopsy | 1 | 2011 | 37 | 0.030 |
Why?
|
Asian Americans | 1 | 2011 | 98 | 0.020 |
Why?
|